Apollo slides as Apollo-managed BDC MFIC cuts dividend and marks down assets, reviving private-credit stress fears

Apollo Global Management (APO) is down 8.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to renewed investor concern about credit marks inside an Apollo-managed direct-lending vehicle after MidCap Financial Investment Corp. (MFIC) cut its dividend and reported a decline in net asset value. The move likely amplified broader risk-off sentiment toward publicly traded alternative asset managers and private-credit exposure.

Details:

MidCap Financial Investment Corp., a business development company overseen by Apollo, declared a quarterly dividend of $0.31 per share, down from $0.38, alongside commentary that the board reassessed longer-term earnings power as base rates and spreads shifted.

MFIC reported net asset value of $14.18 per share at December 31, 2025, down from $14.66 at September 30, 2025, with the decline attributed mainly to a handful of older-vintage investments.

MFIC said the reduced dividend is payable March 26, 2026 to shareholders of record March 10, 2026, and it also authorized a new $100 million share repurchase plan.

Separately, Apollo’s own SEC filing reflected a $0.51 per-share common dividend scheduled to be paid February 27, 2026, suggesting the market reaction was more about credit optics than an Apollo corporate dividend change.

Sources:

GlobeNewswire, The Wall Street Journal, Yahoo Finance

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$APO Insider Trading Activity

$APO insiders have traded $APO stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $APO stock by insiders over the last 6 months:

LEON D BLACK sold 915,000 shares for an estimated $122,637,450
WHITNEY CHATTERJEE (Chief Legal Officer) sold 8,500 shares for an estimated $1,241,256
MARTIN KELLY (Chief Financial Officer) sold 6,000 shares for an estimated $788,433

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$APO Hedge Fund Activity

We have seen 613 institutional investors add shares of $APO stock to their portfolio, and 559 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 16,075,234 shares (-75.7%) from their portfolio in Q4 2025, for an estimated $2,327,050,873
FMR LLC added 5,752,322 shares (+23.3%) to their portfolio in Q4 2025, for an estimated $832,706,132
CAPITAL WORLD INVESTORS removed 4,049,297 shares (-14.3%) from their portfolio in Q4 2025, for an estimated $586,176,233
PRICE T ROWE ASSOCIATES INC /MD/ removed 2,313,437 shares (-39.2%) from their portfolio in Q4 2025, for an estimated $334,893,140
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 2,044,533 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $272,474,912
NORGES BANK added 1,970,183 shares (+29.3%) to their portfolio in Q4 2025, for an estimated $285,203,691
CAPITAL RESEARCH GLOBAL INVESTORS added 1,724,822 shares (+18.6%) to their portfolio in Q4 2025, for an estimated $249,685,232

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$APO Congressional Stock Trading

Members of Congress have traded $APO stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $APO stock by members of Congress over the last 6 months:

REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 11/21.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$APO Analyst Ratings

Wall Street analysts have issued reports on $APO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 11/25/2025
Morgan Stanley issued a "Overweight" rating on 11/20/2025
Evercore ISI Group issued a "Outperform" rating on 11/05/2025

To track analyst ratings and price targets for $APO, check out Quiver Quantitative's $APO forecast page.

$APO Price Targets

Multiple analysts have issued price targets for $APO recently. We have seen 8 analysts offer price targets for $APO in the last 6 months, with a median target of $160.0.

Here are some recent targets:

Michael Brown from UBS set a target price of $152.0 on 02/20/2026
John Barnidge from Piper Sandler set a target price of $165.0 on 02/10/2026
Michael Cyprys from Morgan Stanley set a target price of $181.0 on 02/10/2026
Benjamin Budish from Barclays set a target price of $158.0 on 02/10/2026
Kenneth Worthington from JP Morgan set a target price of $162.0 on 02/10/2026
Kyle Voigt from Keefe, Bruyette & Woods set a target price of $173.0 on 11/05/2025
Glenn Schorr from Evercore ISI Group set a target price of $155.0 on 11/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.